| Product NDC: | 0004-0802 | 
| Proprietary Name: | Tamiflu | 
| Non Proprietary Name: | oseltamivir phosphate | 
| Active Ingredient(s): | 30 mg/1 & nbsp; oseltamivir phosphate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0802 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021087 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19991027 | 
| Package NDC: | 0004-0802-85 | 
| Package Description: | 1 BLISTER PACK in 1 CARTON (0004-0802-85) > 10 CAPSULE in 1 BLISTER PACK | 
| NDC Code | 0004-0802-85 | 
| Proprietary Name | Tamiflu | 
| Package Description | 1 BLISTER PACK in 1 CARTON (0004-0802-85) > 10 CAPSULE in 1 BLISTER PACK | 
| Product NDC | 0004-0802 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | oseltamivir phosphate | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19991027 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | OSELTAMIVIR PHOSPHATE | 
| Strength Number | 30 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |